Notice/News
Notice/News
The external news articles in this bulletin have been collected and published solely for the purpose of providing information and may differ from our official position. We make no guarantee of the accuracy, timeliness, or completeness of the content of the article and are not liable for any direct or indirect damage that may occur.
Notice
[The Bio] ToolGen CEO Yoo Jong-sang Says Priority Proceedings with Broad Are Gaining Momentum, Vows to Secure Gene-Editing IP Rights
주식회사 툴젠
|2026.07.28
더바이오에 당사 기사가 게재되었습니다.
자세한 내용은 아래 링크에서 확인하실 수 있습니다.
■ 기사 원문 : [단독] 유종상 툴젠 대표 “브로드와 선발명 심리 본격화…유전자가위 IP 권리 확보할 것”